Pure Global

MINDRAY SARS-COV-2 IgG(CLIA) Severe Acute Respiratory Syndrome Coronavirus 2 IgG (CLIA) - Indonesia BPOM Medical Device Registration

MINDRAY SARS-COV-2 IgG(CLIA) Severe Acute Respiratory Syndrome Coronavirus 2 IgG (CLIA) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303024068. The device is manufactured by SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO.,LTD from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. MINDRAY MEDICAL INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
MINDRAY SARS-COV-2 IgG(CLIA) Severe Acute Respiratory Syndrome Coronavirus 2 IgG (CLIA)
Analysis ID: AKL 20303024068

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. MINDRAY MEDICAL INDONESIA

AR Address

Menara DEA II Lt.17, Jl. Mega Kuningan Barat Kav.E4.3 No.1-2, Kel. Kuningan Timur, Kec.Setiabudi Kawasan Mega Kuningan, Jakarta Selatan

Registration Date

Dec 30, 2020

Expiry Date

Jun 29, 2025

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing